At Sullivan Dermatology, we strive to provide patients with the most innovative medical care available for their skin conditions. Our research team partners with the world’s top pharmaceutical companies to conduct research and trials that help lead to new, more effective and groundbreaking dermatologic treatments. Putting our patients’ safety first and implementing sound clinical practices is our top priority.

Dr. Tory Sullivan, a Board Certified Dermatologist with over 10 years of experience in conducting clinical trials for FDA approval, is the primary investigator. His research includes testing new medicines for cutaneous conditions such as acne vulgaris, actinic keratosis, psoriasis, hyperhidrosis, and more. Our research staff has more than 25 years of combined experience and includes: Christyn Cullen PA-C and Anna Chockley, Director of Clinical Research.

Current Clinical Trials

If your dermatologic concerns or conditions fit the descriptions below, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com.

Hidradenitis Suppurativa (HS)

(SC Treatment)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female subjects
  • Ages 18 years or older
  • Have been diagnosed with hidradenitis suppurativa for at least 6 months
  • Have Moderate to Severe hidradenitis suppurativa with bumps (or 5 inflammatory lesions present) in or on at least 2 different areas of your body
  • Have previously taken and had inadequate response to a course of systemic antibiotics for the treatment of hidradenitis suppurativa

13 visits during up to a 48 week period; Travel reimbursements: $100 per visit

If your dermatologic concerns or conditions fit the descriptions above, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com

Hidradenitis Suppurativa (HS)

(Oral Treatment)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female subjects
  • Ages 18 years or older
  • Have been diagnosed with hidradenitis suppurativa for at least 12 months
  • Have Moderate to Severe hidradenitis suppurativa with bumps (or 5 inflammatory lesions present) in or on at least 2 different areas of your body
  • Have previously taken and had inadequate response to a course of systemic antibiotics for the treatment of hidradenitis suppurativa

10 visits during up to a 26 week period; Travel reimbursements: $100 per visit

If your dermatologic concerns or conditions fit the descriptions above, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com.

Atopic Dermatitis (Eczema)

(Cream Treatment)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female subjects
  • Ages 12-65 years or older
  • Have been diagnosed with Atopic Dermatitis (Eczema) for at least 6 months
  • Have Mild to Moderate Atopic Dermatitis (Eczema) which is present on an area that measures at least two “Hand Prints” of your skin.

5 visits during up to a 4 week period; Travel reimbursements: $100 per visit

If your dermatologic concerns or conditions fit the descriptions above, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com.

Prurigo Nodularis (PN)

(SC Treatment)

DO YOU MEET THESE REQUIREMENTS?

  • Male or female subjects
  • Ages 18 years or older
  • Have been diagnosed with Prurigo Nodularis (PN) for at least 6 months
  • Have 20 bumps on both sides of your body.
  • Have Severe itching

7 visits during up to a 28 week period; Travel reimbursements: $100 per visit

If your dermatologic concerns or conditions fit the descriptions above, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com.


Dermatology Research
A graduate of Georgetown University, Vanderbilt University Medical School, and the University of Miami, Dr. Sullivan maintains strong ties to the academic and medical community through teaching, clinical research, and peer lecturing nationwide. His findings and advancements from his extensive medical research can be found in publications of the American Society of Dermatologic Surgery, The Wound Healing Society and the European Tissue Repair Society, and the Journal of Cutaneous Medicine and Surgery, among others.

Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses

Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping

Infliximab for hidradenitis suppurativa

Pemphigus and smoking

Surgical pearl: punch technique to improve granulation over exposed tendons in chronic wounds

A liquid adhesive bandage for the treatment of minor cuts and abrasions

The pig as a model for human wound healing

Colchicine in dermatology